drug

natrunix

1 story · latest Aug 14, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by XBiotech, Inc.

Timeline

XBiotech posts Phase 1 results for Natrunix dose-escalation study in healthy volunteers

Aug 14Trial updatenatrunix XBiotech, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.